Rhythm Pharmaceuticals In... (RYTM)
NASDAQ: RYTM
· Real-Time Price · USD
97.69
1.21 (1.25%)
At close: Aug 15, 2025, 3:59 PM
97.50
-0.19%
After-hours: Aug 15, 2025, 06:27 PM EDT
Rhythm Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 135.59M | 106.09M | 89.14M | 47.52M | 161.67M | 53.43M | 60.08M | 64.59M | 115.68M | 109.66M | 127.68M | 185.09M | 113.21M | 78.54M | 59.25M | 92.37M | 69.34M | 87.27M |
Short-Term Investments | 155.44M | 208.39M | 231.43M | 250.87M | 157.46M | 147.77M | 215.76M | 234.67M | 137.92M | 184.92M | 205.61M | 162.71M | 122.39M | 162.43M | 235.61M | 235.98M | 298.81M | 317.48M |
Long-Term Investments | n/a | n/a | n/a | 462K | 460K | 460K | 328K | 328K | 328K | 328K | n/a | 328K | 328K | 328K | 328K | 328K | 328K | 328K |
Other Long-Term Assets | 2.75M | 7.61M | 7.79M | 11.99M | 12.75M | 13.8M | 15.33M | 15.32M | 15.85M | 17.08M | 16.98M | 15.94M | 15.79M | 18.36M | 11.81M | 10.53M | n/a | n/a |
Receivables | 26.12M | 17.82M | 18.51M | 19.31M | 17.6M | 14.7M | 14.87M | 14.54M | 13.83M | 8.12M | 6.22M | 3.33M | 1.71M | 862K | 1.02M | n/a | n/a | n/a |
Inventory | 18.87M | 19.32M | 18.74M | 13.89M | 11.99M | 8.51M | 8.62M | 7.76M | 6.18M | 5.49M | 2.92M | 1.57M | 1.69M | 108K | 111K | n/a | n/a | n/a |
Other Current Assets | 24.66M | 17.66M | 8.8M | 8.75M | 8.64M | 11.35M | 6.67M | 7.64M | 10.27M | 9.65M | 7.42M | n/a | n/a | n/a | 3.99M | 7.28M | 10.3M | 7.38M |
Total Current Assets | 360.68M | 369.29M | 374.2M | 340.34M | 357.37M | 235.75M | 308.27M | 329.2M | 283.88M | 317.84M | 354.24M | 361.87M | 249.33M | 253.45M | 308.39M | 335.64M | 378.45M | 412.13M |
Property-Plant & Equipment | 3.56M | 3.83M | 4.11M | 4.39M | 4.67M | 1.82M | 2.12M | 2.43M | 2.76M | 3.09M | 3.38M | 3.7M | 3.92M | 4.16M | 4.33M | 4.55M | 4.72M | 4.75M |
Goodwill & Intangibles | 5.75M | 5.96M | 6.17M | 6.39M | 6.6M | 6.82M | 7.03M | 7.24M | 7.46M | 7.67M | 7.88M | 8.1M | 8.31M | 8.53M | 4.66M | 4.77M | 4.89M | 5M |
Total Long-Term Assets | 12.05M | 17.4M | 18.07M | 23.23M | 24.48M | 22.9M | 24.48M | 25M | 26.07M | 27.84M | 28.25M | 27.74M | 28.34M | 31.38M | 21.14M | 20.19M | 9.94M | 10.07M |
Total Assets | 372.73M | 386.69M | 392.27M | 363.57M | 381.85M | 258.65M | 332.75M | 354.2M | 309.94M | 345.68M | 382.48M | 389.61M | 277.68M | 284.82M | 329.52M | 355.82M | 388.39M | 422.21M |
Account Payables | 15.98M | 11.91M | 12.33M | 4.89M | 4.54M | 7.55M | 4.88M | 3.84M | 8.38M | 13.35M | 4.8M | 4.93M | 6.01M | 12.01M | 5.74M | 4.61M | 5.01M | 9.15M |
Deferred Revenue | n/a | n/a | 1.29M | 1.29M | 1.29M | 1.29M | 1.29M | 1.29M | 1.29M | 1.43M | 1.43M | 1.76M | 2.31M | 9.44M | 7M | 17.51M | 11.54M | 6.92M |
Short-Term Debt | n/a | n/a | n/a | n/a | 816K | n/a | 770K | 748K | 726K | 705K | n/a | 664K | 644K | 625K | 606K | 588K | 570K | 553K |
Other Current Liabilities | 48.16M | 46.17M | 43.59M | 78.48M | 35.76M | 36.78M | 32.05M | 33.48M | 25.62M | 24.34M | 2.42M | 16.59M | 28.82M | 21.44M | 21.11M | 166K | -229K | -324K |
Total Current Liabilities | 129.46M | 111.82M | 115.52M | 97.61M | 54.72M | 54.16M | 55.2M | 50.14M | 46.1M | 46.03M | 39.81M | 33.1M | 44.57M | 47.27M | 43.43M | 23.47M | 17.46M | 16.85M |
Long-Term Debt | n/a | n/a | n/a | 4.03M | 108.37M | 107.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 106.01M | 107.93M | 108.27M | 105.21M | 35.96M | 35.26M | 107.29M | 105.89M | 80.67M | 78.81M | 77.15M | 73.88M | 35.86M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 109.69M | 111.77M | 112.21M | 113.27M | 287.78M | 142.91M | 107.78M | 106.58M | 81.56M | 79.89M | 78.41M | 75.32M | 37.48M | 1.78M | 1.95M | 10.09M | 19.24M | 24.41M |
Total Liabilities | 239.15M | 223.6M | 227.72M | 352.36M | 342.5M | 197.07M | 162.99M | 156.72M | 127.66M | 125.92M | 118.22M | 108.42M | 82.05M | 49.05M | 45.37M | 33.56M | 36.7M | 41.26M |
Total Debt | 4.19M | 4.06M | 3.94M | 4.03M | 252.64M | 108.44M | 1.26M | 1.44M | 1.61M | 1.78M | 1.94M | 2.1M | 2.26M | 2.41M | 2.55M | 2.69M | 2.83M | 2.96M |
Common Stock | 64K | 62K | 61K | 61K | 60K | 60K | 59K | 59K | 57K | 56K | 56K | 56K | 50K | 50K | 50K | 50K | 50K | 50K |
Retained Earnings | -1.25B | -1.2B | -1.16B | -1.11B | -1.07B | -1.04B | -894.74M | -853.1M | -808.94M | -762.24M | -710.06M | -667.57M | -626.7M | -581.7M | -528.94M | -486.07M | -450.97M | -415.58M |
Comprehensive Income | -2.25M | -51K | -39K | -604K | -617K | -181K | 134K | -113K | -14K | -6K | -92K | -339K | -906K | -629K | -1K | 21K | 21K | -58K |
Shareholders Equity | 133.58M | 163.09M | 164.55M | 11.21M | 39.34M | 61.58M | 169.76M | 197.47M | 182.28M | 219.76M | 264.26M | 281.19M | 195.63M | 235.77M | 284.15M | 322.26M | 351.69M | 380.95M |
Total Investments | 155.44M | 208.39M | 231.43M | 251.33M | 157.92M | 148.23M | 215.76M | 234.67M | 137.92M | 184.92M | 205.61M | 162.71M | 122.39M | 162.43M | 235.61M | 235.98M | 298.81M | 317.48M |